Vision Ease, LP Strategic SWOT Analysis Review [Report Updated: 27072017] Prices from USD $125

15:41 EDT 9 Aug 2017 | BioPortfolio Report Blog

Vision Ease, LP Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This uptotheminute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


Business description A detailed description of the company's operations and business divisions.
Corporate strategy GlobalData's summarization of the company's business strategy.
SWOT analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.
Key manufacturing facilities A list of key manufacturing facilities of the company.


Vision Ease, LP VEL is a lens manufacturer. The company is a subsidiary of HOYA Corporation. It designs, manufactures and distributes polycarbonate ophthalmic lenses. The company offers a broad range of lenses including, polarized, light responsive lenses, progressive lenses, performance coatings lenses and performance lenses. VEL markets its products under the brand names Coppertone, SunRx, LifeRx, Outlook, Tegra, Illumina, Thindex and Novella. The company distributes its products through independent opticians, ophthalmologists and optometrists. The company also distributes its products through various retail chains and dispensing markets in the US. The company distributes and markets its products through its offices and sales representatives in Latin America, Europe and Canada. VEL is headquartered in Ramsey, Minnesota, the US.

Vision Ease, LP Key Recent Developments

Aug 18,2016: Luiz de Freitas Joins VISION EASE as Commercial Director for Mexico
Apr 15,2016: VISION EASE Introduces Clear Blue Filter Lenses
Apr 07,2016: VISION EASE expands global sales and marketing capabilities with three new appointments
Mar 02,2016: VISION EASE Launches Line of Single Vision 1.67 HighIndex Lenses
Jan 28,2016: Tony Brea named Vice President of Latin America Business for VISION EASE

Reasons to Buy

Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Original Article: Vision Ease, LP Strategic SWOT Analysis Review [Report Updated: 27072017] Prices from USD $125


More From BioPortfolio on "Vision Ease, LP Strategic SWOT Analysis Review [Report Updated: 27072017] Prices from USD $125"

Quick Search

Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...